J&J Louisiana Talc Verdict Appeal Fails: Court Upholds Judge's Tripling of Henderson Mesothelioma Award
In the J&J Louisiana talc verdict appeal, the Fourth Circuit on November 16, 2026 affirmed the Henderson mesothelioma judgment, including a trial judge's increase of a $3 million jury verdict to more than $9 million in total damages.
Torts Desk··17 min read

The J&J Louisiana talc verdict appeal ended in defeat for Johnson & Johnson on Monday, November 16, 2026, when Louisiana's Fourth Circuit Court of Appeal affirmed the judgment in the Jeannine Henderson mesothelioma case, including an Orleans Parish trial judge's decision to raise the jury's general damages from $255,000 to $4.5 million and each son's award from $90,000 to $1 million. The result turns a $3 million May 2025 jury verdict into a judgment that the family's lawyers put at more than $9 million, and it confirms that in Louisiana a trial judge who finds a jury's damages unreasonably low can rewrite them and have that rewrite survive appeal.
The ruling, on consolidated appeals Nos. 2026-CA-0208 and 2026-CA-0209, was announced on November 17 by the family's trial firm, Dean Omar Branham Shirley, which tried the case with the New Orleans firm of Philip C. Hoffman. According to the release, the appellate panel rejected all three of J&J's main lines of attack: the sufficiency of the evidence behind the jury's findings, the trial court's instructions on causation, and the increase in damages. The opinion text was not available from the court or a public database at the time of writing, so this analysis relies on the parties' public statements, defense-side and trade reporting of the trial, and the governing Louisiana law. Where sources disagree, the disagreement is flagged rather than resolved by guesswork.
What follows sets out what the Fourth Circuit decided, reconciles the different dollar figures in circulation, explains how a Louisiana judge can lawfully triple a jury's award, walks through the fault-allocation fight that turns on when Mrs. Henderson was first exposed to asbestos, places the case beside J&J's other recent talc results, and closes with what the decision means for claimants' counsel, defendants, insurers and funders.
What did the Louisiana appeals court decide in the Henderson J&J talc case?
The Fourth Circuit affirmed. The family's release states that the court upheld the trial court's decision to increase damages awarded to the family and rejected Johnson & Johnson's challenges to the jury's findings, to the trial court's instructions on causation, and to the subsequent increase in damages. HarrisMartin, the asbestos and talc trade reporter, independently described the ruling as an affirmance of the award entered against J&J.
Three holdings follow from that description:
- Sufficiency of the evidence. The jury had found, by a 9-2 vote, that Mrs. Henderson had significant exposure to asbestos from talc products manufactured or sold by J&J and its affiliate Pecos River Talc LLC, and that the exposure was a substantial factor in causing her mesothelioma. The appellate court left that finding intact. Under Louisiana's manifest-error standard of review, an appellate court may not set aside a jury's factual findings unless they are clearly wrong, so an affirmance on this point signals that the panel found a reasonable evidentiary basis for the jury's view that J&J's talc contained asbestos.
- Causation instructions. J&J challenged how the jury was told to evaluate causation. In Louisiana asbestos litigation, plaintiffs typically must show significant exposure to the defendant's product and that the exposure was a substantial contributing factor in causing the disease. The panel found no reversible error in the instructions given.
- The damages increase. The panel upheld the trial judge's decision to replace the jury's general damages figures with much larger ones. That is the holding with the widest practical reach, and it is discussed in detail below.
Plaintiffs' counsel characterized the outcome as a finding that J&J's position on asbestos in its talc is against the weight of the evidence. That is an advocate's gloss. What the reported holdings establish is narrower: that the jury's verdict on exposure and causation was supported by the record, and that the trial judge acted within the law in increasing damages.
How much does J&J owe in the Henderson mesothelioma case?
The honest answer is that public sources do not yet allow a precise figure for J&J's individual liability, and three different numbers are in circulation. The table reconciles them.
| Stage | Mrs. Henderson general damages | Medical expenses | Each son (Joshua, Justin) | Total | Source |
|---|---|---|---|---|---|
| Jury verdict, May 7, 2025 | $255,000 ($85,000 each for pain and suffering, mental anguish, loss of enjoyment of life) | $2,570,206.09 | $90,000 | $3,005,206.09 | Verdict reporting; plaintiffs' release |
| After trial court increase | $4,500,000 | $2,570,206.09 | $1,000,000 | $9,070,206.09 | Plaintiffs' release ("exceeds $9 million") |
| Trade press headline on affirmance | n/a | n/a | n/a | $6.7 million "award entered" | HarrisMartin |
The medical-expense figure is derived: the reported $3,005,206.09 verdict, less $255,000 in general damages and $180,000 for the two sons, leaves $2,570,206.09, which matches the release's description of a $2.57 million medical award. Applying the same arithmetic to the post-increase figures yields total damages of about $9.07 million, consistent with the release's statement that the judgment exceeds $9 million.
The $6.7 million figure cannot be reconciled from public material. It may reflect the amount of the judgment actually cast against J&J after the trial court resolved how fault and liability were divided among the defendants and the non-parties, or it may reflect another adjustment; neither the release nor the publicly available portion of the HarrisMartin report explains it. Readers relying on any single number should treat $9.07 million as gross damages and $6.7 million as a reported figure for the judgment entered, pending the opinion. Judicial interest, which in Louisiana runs on tort judgments from the date of judicial demand, will add materially to whatever principal J&J ultimately owes on a case filed in 2022.
Why did the trial judge increase the jury's damages award?
Because the jury's award for Mrs. Henderson's own suffering was strikingly low relative to the medical evidence and to Louisiana mesothelioma awards generally. The jury found J&J liable and awarded more than $2.5 million in medical expenses, but only $85,000 in each of three categories for a disease that is almost uniformly fatal and that, in Mrs. Henderson's case, ended in her death in January 2024 while her first trial was under way. The jury also awarded each son only $90,000.
Plaintiffs moved after the verdict for relief from those figures. The trial judge agreed that the general damages could not stand and replaced them with $4.5 million for Mrs. Henderson's pain and suffering and $1 million for each son. The family's release does not use a procedural label for the motion, and the opinion has not been published, so whether the increase came through judgment notwithstanding the verdict or through additur is not confirmed in public sources. The distinction matters, because the two devices work very differently under Louisiana law.
Can a Louisiana judge increase a jury's damages award?
Yes, by two routes, and the Henderson affirmance shows that the higher number can survive appellate scrutiny.
Judgment notwithstanding the verdict (JNOV). Article 1811 of the Louisiana Code of Civil Procedure allows a party to move for JNOV within seven days after notice of judgment, and article 1811(F) permits a JNOV on liability, on damages, or both. The article itself does not set the test. The Louisiana Supreme Court supplied it in Anderson v. New Orleans Public Service, Inc., 583 So. 2d 829 (La. 1991): a JNOV is warranted only when the facts and inferences point so strongly and overwhelmingly in favor of the moving party that reasonable jurors could not have reached a contrary verdict. The trial judge may not weigh evidence, judge credibility or substitute personal views for the jury's. If that high bar is cleared on damages, the judge becomes the trier of fact and makes an independent assessment of the proper award. On appeal, a court first asks whether the JNOV was properly granted under Anderson, and if it was, reviews the judge's new figure for manifest error or abuse of discretion.
Additur. Article 1814 allows a trial court that considers a damages award inadequate to offer the losing party a choice: accept an increased award or face a new trial. Additur depends on the defendant's consent; if the defendant declines, the remedy is a new trial on damages, not an imposed number.
The appellate outcome in Henderson is consistent with either route, but the structure of the case points toward JNOV. Under additur, J&J would have had to agree to the increase, which sits awkwardly with an appeal attacking it. Under JNOV, the increase is imposed and can be challenged directly, which is what J&J did. If the opinion confirms a JNOV, Henderson becomes a notable example of a Louisiana appellate court approving a trial judge's conclusion that no reasonable jury could have awarded $255,000 for mesothelioma suffering, and approving an increase of more than seventeenfold to the decedent's general damages.
For defense counsel, the lesson is that a low general-damages verdict paired with a liability finding is not a safe harbor in Louisiana state court. For plaintiffs' counsel, it is a reminder that a disappointing damages figure is worth a post-trial motion when the record on suffering is strong and the jury has otherwise accepted liability and causation.
How did the jury allocate fault in Henderson v. Johnson & Johnson?
The jury returned a mixed verdict after an eight-week trial in Orleans Parish Civil District Court. It found for the plaintiffs on negligence, strict liability and Failure to Warn theories, and rejected the Design Defect claim. It voted 9-2 that Mrs. Henderson had significant exposure to asbestos from talc products of J&J and/or Pecos River Talc that was a substantial factor in causing her mesothelioma, and it found unanimously that J&J knew of the risks posed by its product, according to the plaintiffs' account of the verdict. Louisiana allows Punitive Damages only where a statute authorizes them, and none were awarded.
Fault was divided as follows:
| Party | Status at trial | Fault assigned |
|---|---|---|
| Johnson & Johnson | Defendant | 45% |
| Pecos River Talc LLC | Defendant (J&J affiliate) | 2% |
| Johns Manville | Non-party | 45% |
| Avon | Non-party | 8% |
Assigning fault to non-parties such as Johns Manville, a historic asbestos manufacturer whose liabilities were channeled to a trust in bankruptcy, is common in asbestos trials, and it is often the single largest variable in what the trial defendant actually pays. In a pure comparative-fault system, J&J's 45% share would cap its liability at 45% of the damages. But Louisiana asbestos law does not always apply comparative fault, and that is where Henderson became contested.
Why does the date of asbestos exposure matter in Louisiana talc cases?
Because Louisiana applies the law in effect when the plaintiff was significantly exposed, not the law in effect when the suit was filed or the disease was diagnosed. Louisiana adopted comparative fault in 1980. Before that, joint tortfeasors were solidarily liable and shared liability among themselves by virile shares: equal, per-head portions regardless of relative blame.
The Louisiana Supreme Court applied that framework to asbestos cases in Cole v. Celotex Corp., 599 So. 2d 1058 (La. 1992), holding that where a plaintiff's significant, injury-producing asbestos exposure occurred before the 1980 comparative-fault law took effect, pre-1980 law governs allocation. Austin v. Abney Mills, Inc., 824 So. 2d 1137 (La. 2002), confirmed that asbestos causes of action arise at the time of significant exposure. Defendants have long argued for narrow readings of those cases, and the Louisiana Supreme Court's later decision in Walls v. American Optical Corp. (La. 1999) described Cole as turning on the specific wording of the comparative-fault statute.
In Henderson, the two sides proposed judgments that differed sharply, according to Goldberg Segalla's tracking of the post-trial briefing:
| Position | Theory | Proposed figure against J&J | Proposed figure against Pecos River |
|---|---|---|---|
| Plaintiffs | Exposure predated 1980; survival damages of $2,825,206 split equally between the two trial defendants as virile shares | About half of $2,825,206 each, with the pair answering for the full survival award | About half of $2,825,206 |
| Defendants | Comparative fault applies; each defendant pays its percentage | $1,352,342 (45%) | $60,104 (2%) |
Two details are worth noticing. First, the plaintiffs' proposed survival figure, $2,825,206, is exactly the jury's general damages ($255,000) plus medical expenses ($2,570,206.09): the plaintiffs separated Mrs. Henderson's own survival claim, which they say arose from pre-1980 exposure, from the sons' wrongful death awards. Louisiana courts have treated wrongful death claims as arising at death, so the law in effect when Mrs. Henderson died in 2024 may govern those awards even when pre-1980 law governs the survival claim. Second, the plaintiffs' approach ignored the non-party fault entirely; under virile shares, liability is divided among the solidary obligors actually cast in judgment, with adjustments for parties that have settled. The Hoffman firm said after the verdict that, under Louisiana law, J&J would be responsible for more than 95% of the award.
How the trial court resolved that dispute, and whether the Fourth Circuit addressed it, is not stated in the plaintiffs' release. The gap between the $9.07 million gross figure and the $6.7 million figure reported by HarrisMartin is consistent with some allocation having been applied, but the mechanics remain unconfirmed until the opinion is available. What is clear is that a 45% fault finding did not translate into a 45% liability cap, and that the exposure-date question can shift millions of dollars between a trial defendant and the bankruptcy trusts and non-parties assigned fault.
What role does Pecos River Talc play?
Pecos River Talc LLC is the J&J affiliate created in the company's 2024 restructuring to hold mesothelioma and certain other talc claims. When J&J's third talc bankruptcy, through affiliate Red River Talc LLC, was dismissed by Judge Christopher Lopez of the Bankruptcy Court for the Southern District of Texas on March 31, 2025, the proposed plan had covered ovarian and gynecological cancer claims; mesothelioma claims were excluded and left in the tort system. Pecos River has since been a named defendant in mesothelioma trials alongside J&J, as it was in Henderson, where it was described as the supplier of the talc used in Johnson's Baby Powder.
The 2% fault share the jury assigned to Pecos River is small, but it matters under a virile-share theory: if liability is split per head among solidary obligors, an affiliate with 2% of the fault can carry an equal share of the survival award, and because both are J&J entities, the economic burden lands in the same corporate family either way.
How does Henderson compare with J&J's other recent talc results?
Henderson is the latest in a run of state-court mesothelioma outcomes that continue to be tried individually, one case at a time, while the company focuses its Global Settlement efforts on ovarian cancer claims.
| Case | Court | Date | Result | J&J share or note |
|---|---|---|---|---|
| Henderson | Orleans Parish CDC; La. 4th Cir. | Verdict May 7, 2025; affirmed Nov. 16, 2026 | $3.0M verdict increased to about $9.07M | 45% fault; $6.7M award entered per HarrisMartin |
| Roy | Orleans Parish CDC | Aug. 21, 2026 | $10M verdict ($8M survival; $1M to each daughter) | About $1.2M per most reports |
| Reikes | Alameda County Superior Court, Cal. | Nov. 9, 2026 | $34.21M verdict | 40% fault; Proposition 51 applies |
| Haddad | Massachusetts state court | Nov. 6, 2026 | About $1.9M verdict | Plaintiff verdict |
The Roy and Henderson comparison is instructive. Both were tried in the same New Orleans courthouse. In Roy, the jury itself awarded $8 million for the decedent's suffering, and J&J's share was cut to about $1.2 million because jurors assigned substantial fault to co-defendants and other talc suppliers. In Henderson, the jury awarded only $255,000 for suffering, but the trial judge raised it to $4.5 million and the fault structure left J&J with a far larger share. The variable that most affects J&J's bill in Louisiana is not the headline verdict but the combination of general-damages valuation, the identity of other parties assigned fault, and the exposure-date rule.
What did J&J say?
No J&J statement on the November 16 ruling was located at the time of writing. After the May 7, 2025 verdict, Erik Haas, J&J's worldwide vice president of litigation, said the company would appeal a verdict that, in his words, "emanated from multiple reversable errors," and that it fully expected the award against it to be reversed. J&J's consistent public position is that its talc is safe, does not contain asbestos and does not cause cancer. The Fourth Circuit's affirmance rejects the company's appellate arguments in this case but does not bind any other court on the science.
Will J&J appeal to the Louisiana Supreme Court?
J&J has two further options, and its litigation history suggests it will use at least one of them. First, it may apply to the Fourth Circuit for rehearing, which under the Uniform Rules of the Louisiana Courts of Appeal must be filed within 14 days of the mailing of notice of the judgment. Second, it may apply to the Louisiana Supreme Court for a writ of certiorari; under Louisiana Code of Civil Procedure article 2166, the application is due within 30 days of the mailing of notice of the appellate judgment, or of the denial of a timely rehearing application.
Review by the Louisiana Supreme Court is discretionary. The court grants writs sparingly, typically where there is a conflict among the circuits, a significant unresolved question of law, or a result it views as gravely erroneous. J&J's best candidates for a writ are the allocation question, if the Fourth Circuit applied pre-1980 solidary liability in a way that departs from other circuits, and the scope of a trial judge's power to raise general damages on JNOV, if that is what occurred. A pure sufficiency-of-evidence argument is unlikely to attract review.
Does J&J's $5.5 billion talc settlement cover mesothelioma claims like Henderson?
No. J&J's proposed resolution, announced July 27, 2026, is limited to ovarian cancer and related gynecological claims, roughly 76,000 of them across the federal Multidistrict Litigation (MDL) in the District of New Jersey and state courts, and is conditioned on 95% participation. Mesothelioma claims were also outside the Red River plan that failed in 2025. They continue to be litigated individually in state courts, principally in jurisdictions such as Louisiana, California, Massachusetts, Illinois and New Jersey, and they are resolved through trial verdicts or individual and inventory settlements rather than a single matrix. Henderson therefore has no direct effect on the ovarian deal's participation count, but it adds to the cost and uncertainty of the mesothelioma docket that J&J is managing separately.
What it means for claimants, defendants, insurers and funders
For claimants' counsel in Louisiana talc and asbestos cases. Henderson is a practical template. A jury that accepts liability and causation but undervalues suffering does not end the case; a well-supported post-trial motion can move general damages into the range the evidence supports, and the Fourth Circuit has now affirmed such a move in a talc case. The exposure-date record matters as much as the damages record: evidence that significant exposure began before 1980 can shift the case from comparative fault to virile shares and change who pays. Separating survival and wrongful death damages in the proposed judgment, as the Henderson plaintiffs did, frames the allocation fight cleanly.
For J&J and other talc and cosmetic defendants. Non-party fault assignments to bankrupt asbestos manufacturers are less protective in Louisiana when exposure predates 1980. Defense trial strategy has to account for the risk that a favorable damages verdict will be increased post-trial, which may change how damages are argued to the jury and whether additur offers are accepted. The appellate path now runs through a discretionary writ application, which narrows the arguments worth pressing.
For insurers. Historic occurrence-based policies triggered by pre-1980 exposure sit underneath judgments like this one. Solidary liability with virile shares concentrates the loss on the defendants actually cast in judgment, and judicial interest from a 2022 filing date adds a meaningful amount on top of principal.
For funders and mass tort portfolio managers. Third-Party Litigation Funding underwriting for mesothelioma inventories turns on jurisdiction-specific allocation rules, not just verdict sizes. Henderson and Roy, tried in the same courthouse three months apart, produced very different exposures for J&J because of fault allocation and post-trial practice. Valuation models that treat a Louisiana verdict's headline as the recovery will misprice the cases in both directions.
Timeline
| Date | Event |
|---|---|
| Before 1980 | Plaintiffs contend Mrs. Henderson's significant exposure began, triggering pre-comparative-fault law |
| 2022 | Suit filed in Orleans Parish Civil District Court, No. 2022-10279 |
| January 2024 | Mrs. Henderson dies of mesothelioma after her first trial had begun |
| March 31, 2025 | Red River Talc bankruptcy dismissed; mesothelioma claims had been excluded from its plan |
| May 7, 2025 | Jury returns $3,005,206.09 verdict; 9-2 on exposure and causation; J&J 45% at fault |
| 2025 (exact dates not public) | Parties brief comparative fault versus virile shares; trial judge raises general damages |
| August 21, 2026 | Separate Orleans Parish jury returns $10 million Roy verdict against J&J |
| November 16, 2026 | Fourth Circuit affirms in Nos. 2026-CA-0208 and 2026-CA-0209 |
| November 17, 2026 | Family's counsel announces the ruling |
| Next 14 to 30 days | Window for rehearing application and Louisiana Supreme Court writ application |
FAQ
What did the Louisiana appeals court decide in the Henderson J&J talc case?
On November 16, 2026, Louisiana's Fourth Circuit Court of Appeal affirmed the Henderson mesothelioma judgment against Johnson & Johnson, rejecting J&J's challenges to the jury's findings, the causation instructions and the trial judge's increase in damages.
How much was the Henderson verdict against J&J?
The jury awarded $3,005,206.09 on May 7, 2025. After the trial judge raised general damages to $4.5 million for Mrs. Henderson and $1 million for each son, total damages came to about $9.07 million; HarrisMartin reports a $6.7 million award entered against J&J.
Can a judge increase a jury's damages award in Louisiana?
Yes. A Louisiana trial judge may grant judgment notwithstanding the verdict on damages under Code of Civil Procedure article 1811 when no reasonable jury could have reached the award, and then set a new figure; additur under article 1814 is also available but requires the defendant's consent.
Why does pre-1980 asbestos exposure matter in Louisiana?
Under Cole v. Celotex, if significant asbestos exposure occurred before Louisiana adopted comparative fault in 1980, pre-1980 law governs, and solidarily liable defendants may share liability by equal virile shares rather than by their percentage of fault.
Will J&J appeal the Henderson ruling?
J&J may seek rehearing in the Fourth Circuit within 14 days and apply for a writ of certiorari to the Louisiana Supreme Court within 30 days; the company said in 2025 that it expected the award to be reversed, but review by the state supreme court is discretionary.
Is the Henderson case part of the J&J talc settlement?
No. J&J's proposed $5.5 billion talc resolution covers ovarian and gynecological cancer claims only; mesothelioma cases like Henderson remain in the tort system and are tried or settled individually.
Published for legal professionals. Analysis and summaries only — not legal advice, and no attorney-client relationship is created by use of this site.
Read next

J&J $34 Million Talc Verdict: Alameda Jury Splits Fault 40/60 With Dr. Scholl's in Reikes Mesothelioma Case
In the J&J $34 million talc verdict, an Alameda County jury on November 9, 2026 awarded Kevin and Tina Reikes $34.21 million but put only 40% of fault on Johnson & Johnson, with 60% on Dr. Scholl's foot powder. Under Proposition 51, that split shapes what J&J actually pays.
Torts Desk · 19 min

J&J Massachusetts Talc Verdict: Jury Awards $1.9 Million for Mesothelioma but Rejects Death Claim
In the J&J Massachusetts talc verdict, a Boston jury on November 6, 2026 found Johnson & Johnson's talc caused a former nurse's mesothelioma but not her death, awarding about $1.9 million against a $60 million ask. J&J says it will appeal immediately; the split reshapes damages math for Massachusetts talc trials.
Torts Desk · 17 min

J&J Talc Settlement Participation Hits 87.5%: 313 Firms In, About 5,700 Claims Short of 95%
Lead plaintiffs' counsel told the MDL 2738 court that 313 firms holding about 66,500 ovarian talc claims have signed J&J's $5.5 billion deal, 87.5% against a 95% condition. Meanwhile a Boston jury is hearing a mesothelioma case the deal never covered.
Torts Desk · 19 min